VEGF and eNOS genes polymorphism features in patients with diabetes mellitus with and without initial non-proliferative diabetic retinopathy

The endothelial NO synthase (eNOS) and vascular endothelial growth factor (VEGF) imbalance and the polymorphism of these genes may be the predisposition for diabetic retinopathy (DR) development and progression.
The aim: to analyze VEGF (rs699947 and rs3025039) and eNOS (rs2070744) genes polymorphism and their combinations in patients with type 2 diabetes mellitus (DM2) with and without initial non-proliferative DR.
Materials and methods. The study included 200 patients with type 2 diabetes (155 women and 45 men, age – 43–70 years): 111 people without and 89 people with DR. The polymorphism of the regulatory regions of VEGF (rs699947 and rs3025039) and eNOS (rs2070744) genes was studied using restriction fragment length polymorphism analysis and TaqMan Real-Time PCR by. Statistical processing was carried out using the software packages Statistica 10.0, SPSS Statistics 23 and the package of original programs for volumetric processing of bioinformation.
Results. The VEGF-2578 heterozygosity and two complex genotypes – VEGF-2578CA:VEGF+936CC and NOS3-786CT:VEGF-2578CA:VEGF+936CC – signifi cantly decreased in patients with DR. The predisposition to early DR development to minor genotype of eNOS gene in the NOS3-786CC:VEGF+936CT complex and signifi cantly decreased the homozygous wild-type eNOS genotype in DM2 patients with ophthalmopathology were shown. NOS3-86TT:VEGF2578AA genotype signifi cantly decreased in group with retinopathy developing and the glycated hemoglobin high level.
Conclusion. Along with the clinical risk factors for the development of DR in DM2, the genetic polymorphism of the regulatory regions of the genes analyzed by us has a signifi cant weight. When analyzing potential genetic markers, it is important to consider possible joint epistatic/hypostatic effects. The complex analysis of polymorphic gene can help early prognosis of the DR development.

1. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015; 2: 17. doi: 10.1186/s40662-015-0026-2

2. Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: Current understanding, mechanisms, and treatment strategies. JCI Insight. 2017; 2(14): e93751. doi: 10.1172/jci.insight.93751

3. Opatrilova R, Kubatka P, Caprnda M, Busselberg D, Krasnik V, Vesely P, et al. Nitric oxide in the pathophysiology of retinopathy: Evidences from preclinical and clinical researches. Review Article. Acta Ophthalmol. 2018; 96(3): 222-231. doi: 10.1111/aos.13384

4. Aiello LP, Wong J-S. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl. 2000; 77: S113-S119. doi: 10.1046/j.1523-1755.2000.07718.x

5. Abdelghany AA, Toraih EA, Mohamed AA, Lashine RM, Mohammad MH, Nafie MS, et al. Association of VEGF gene family variants with central macular thickness and visual acuity after aflibercept short-term treatment in diabetic patients: A pilot study. Ophthalmic Res. 2021; 64(2): 261-272. doi: 10.1159/000511087

6. Ha JM, Jin SY, Lee HS, Shin HK, Lee DH, Song SH, et al. Regulation of retinal angiogenesis by endothelial nitric oxide synthase signaling pathway. Korean J Physiol Pharmacol. 2016; 20(5): 533-538. doi: 10.4196/kjpp.2016.20.5.533

7. Vielma AH, Retamal MA, Schmachtenberg O. Nitric oxide signaling in the retina: What have we learned in two decades? Brain Res. 2012; 1430: 1112-1125. doi: 10.1016/j.brainres.2011.10.045

8. Amer AK, Khalaf NA, Aboelmakarem SH, Elsobky MS, Abdelrasoul MR, Abdelazeem AA, et al. Vascular endothelial growth factor +405G/C polymorphism as a predictor of diabetic retinopathy. Bull Natl Res Cent. 2020; 44: 54. doi: 10.1186/s42269-020-00287-y

9. Doshi AA, Ziolo MT, Wang H, Burke E, Lesinski A, Binkley P. A promoter polymorphism of the endothelial nitric oxide synthase gene is associated with reduced mRNA and protein expression in failing human myocardium. J Card Fail. 2010; 16(4): 314-319. doi: 10.1016/j.cardfail.2009.12.013

10. Guo L, Jiang F, Tang Y-T, Si M-Y, Jiao X-Y. The association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease. Diabetes Technol Ther. 2014; 16(4): 224-234. doi: 10.1089/dia.2013.0181

11. Glantz S. Statistics in medicine and biology. Moscow: Praktika; 1998. (In Russ.).

12. Rebrova OYu. Statistical analysis of the medical data. Using a package of applied Statistica programs. Moscow: Mediasfera; 2002. (In Russ.).

13. Buyul А., Tsefel P. SPSS: The art of information processing. Analysis of statistical data and recovery of hidden patterns. Saint Petersburg: DiaSoftYuP; 2005. (In Russ.).

14. Shakhmeister A.H. Combinatorics. Statistics. Probability. Moscow: MTsNMO; 2010. (In Russ.).

15. Hampton B, Schwartz S, Brantley MA Jr, Flynn HW Jr. Update on genetics and diabetic retinopathy. Clin Ophthalmol. 2015; 9: 2175-2193. doi: 10.2147/OPTH.S94508

16. Looker HC, Nelson RG, Chew E, Klein R, Klein BE, Knowler WC, et al. Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes. 2007; 56(4): 1160-1166. doi: 10.2337/db06-1299

17. Xie XJ, Yang YM, Jiang JK, Lu YQ. Association between the vascular endothelial growth factor single nucleotide polymorphisms and diabetic retinopathy risk: A meta-analysis. J Diabetes. 2017; 9(8): 738-753. doi: 10.1111/1753-0407.12480

18. Hu L, Gong C, Chen X, Zhou H, Yan J, Hong W. Associations between vascular endothelial growth factor gene polymorphisms and diff erent types of diabetic retinopathy susceptibility: A systematic review and meta-analysis. J Diabetes Res. 2021; 2021: 7059139. doi: 10.1155/2021/7059139

19. Yang Q, Zhang Y, Zhang X, Li X, Liu J. Association of VEGF gene polymorphisms with susceptibility to diabetic retinopathy: A systematic review and meta-analysis. Horm Metab Res. 2020; 52(5): 264-279. doi: 10.1055/a-1143-6024

20. Wu L, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes. 2013; 4(6): 290-294. doi: 10.4239/wjd.v4.i6.290

21. Jampo LM. Classifications of diabetic macular edema. Eur J Ophthalmol. 2020; 30(1): 6-7. doi: 10.1177/1120672119889532

22. Choi SH, Ruggiero D, Sorice R, Song C, Nutile T, Smith AV, et al. Six novel loci associated with circulating VEGF levels identified by a meta-analysis of genome-wide association studies. PLoS Genet. 2016; 12(2): e1005874. doi: 10.1371/journal.pgen.1005874

23. Bazzaz JT, Amoli MM, Pravica V, Chandrasecaran R, Boulton AJ, Larijani B, et al. eNOS gene polymorphism association with retinopathy in type 1 diabetes. Ophthalmic Genet. 2010; 31(3): 103-107. doi: 10.3109/13816810.2010.482553

24. Zago AS, Kokubun E, Fenty-Stewart N, Park JY, Attipoe S, Hagberg J, et al. Effect of physical activity and t-786C polymorphism in blood pressure and blood flow in the elderly. Arq Bras Cardiol. 2010; 95(4): 510-516. doi: 10.1590/S0066-782X2010005000126

25. Silva RF, Trapé ÁA, Reia TA, Lacchini R, Oliveira-Paula GH, Pinheiro LC, et al. Association of endothelial nitric oxide synthase (eNOS) gene polymorphisms and physical fitness levels with plasma nitrite concentrations and arterial blood pressure values in older adults. PLoS One. 2018; 13(10): e0206254. doi: 10.1371/journal.pone.0206254

26. Gui F, You Z, Fu S, Wu H, Zhang Y. Endothelial dysfunction in diabetic retinopathy. Front Endocrinol (Lausanne(. 2020; 11: 591. doi: 10.3389 / fendo.2020.00591

27. Chen CF, Liou SW, Wu HH, Lin CH, Huang LS, Woung LC, et al. Regulatory SNPs alter the gene expression of diabetic retinopathy associated secretary factors. Int J Med Sci. 2016; 13(9): 717-723. doi: 10.7150/ijms.16345

28. Joshi MS, Berger PJ, Kaye DM, Pearson JT, Bauer JA, Ritchie RH. Functional relevance of genetic variations of endothelial nitric oxide synthase and vascular endothelial growth factor in diabetic coronary microvessel dysfunction. Clin Exp Pharmacol Physiol. 2013; 40(4): 253-261. doi: 10.1111/1440-1681.12070